The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
出版年份 2013 全文链接
标题
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
作者
关键词
-
出版物
Nutrition & Diabetes
Volume 3, Issue 5, Pages e68-e68
出版商
Springer Nature
发表日期
2013-05-27
DOI
10.1038/nutd.2013.9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
- (2012) Cristoforo Silvestri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
- (2012) Jie Liu et al. GASTROENTEROLOGY
- Contrasts between the effects of zinc-α2-glycoprotein, a putative β3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice
- (2012) Edward T Wargent et al. JOURNAL OF ENDOCRINOLOGY
- Overexpression of Cannabinoid CB2 Receptor in the Brain Induces Hyperglycaemia and a Lean Phenotype in Adult Mice
- (2012) S. Y. Romero-Zerbo et al. JOURNAL OF NEUROENDOCRINOLOGY
- Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors
- (2011) Sándor Bátkai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Risk of Depressive Episodes with Rimonabant
- (2011) Yvonne Buggy et al. DRUG SAFETY
- Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk
- (2011) David R Janero et al. Expert Opinion on Drug Discovery
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Peripheral effects of the endocannabinoid system in energy homeostasis: Adipose tissue, liver and skeletal muscle
- (2011) Cristoforo Silvestri et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
- (2010) Daniele Bolognini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulation of nausea and vomiting by cannabinoids
- (2010) Linda A Parker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
- (2010) J. Agudo et al. DIABETOLOGIA
- Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
- (2009) Gernot Riedel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Food Intake-independent Effects of CB1 Antagonism on Glucose and Lipid Metabolism
- (2009) Daniela Cota et al. Obesity
- Dietary Capsaicin Reduces Obesity-induced Insulin Resistance and Hepatic Steatosis in Obese Mice Fed a High-fat Diet
- (2009) Ji-Hye Kang et al. Obesity
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes
- (2008) L. Tedesco et al. DIABETES
- The endocannabinoid system in obesity and type 2 diabetes
- (2008) V. Di Marzo DIABETOLOGIA
- Increased Energy Expenditure Contributes More to the Body Weight-Reducing Effect of Rimonabant than Reduced Food Intake in Candy-Fed Wistar Rats
- (2008) Andreas W. Herling et al. ENDOCRINOLOGY
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- The psychoactive plant cannabinoid, Δ9-tetrahydrocannabinol, is antagonized by Δ8- and Δ9-tetrahydrocannabivarin in mice in vivo
- (2007) R G Pertwee et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice
- (2007) Lola Weiss et al. NEUROPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started